Probiotics and bone disorders: the role of RANKL/RANK/OPG pathway

N Amin, V Boccardi, M Taghizadeh… - Aging clinical and …, 2020 - Springer
The skeleton is the framework and in charge of body configuration preservation. As a living
tissue, bones are constantly being formed and absorbed. Osteoblasts and osteoclasts are …

Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approaches

A Fraldi, M Serafini, NC Sorrentino, B Gentner… - Italian journal of …, 2018 - Springer
Mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders caused by a
deficiency in lysosomal enzymes catalyzing the stepwise degradation of …

β2-Adrenergic signal transduction plays a detrimental role in subchondral bone loss of temporomandibular joint in osteoarthritis

K Jiao, LN Niu, Q Li, G Ren, C Zhao, Y Liu, FR Tay… - Scientific reports, 2015 - nature.com
The present study tested whether activation of the sympathetic tone by aberrant joint loading
elicits abnormal subchondral bone remodeling in temporomandibular joint (TMJ) …

[HTML][HTML] Mesenchymal stromal cells shape the MDS microenvironment by inducing suppressive monocytes that dampen NK cell function

D Sarhan, J Wang, US Arvindam, C Hallstrom… - JCI insight, 2020 - ncbi.nlm.nih.gov
Altered BM hematopoiesis and immune suppression are hallmarks of myelodysplastic
syndrome (MDS). While the BM microenvironment influences malignant hematopoiesis, the …

Bone marrow-derived mesenchymal stromal cells: a novel target to optimize hematopoietic stem cell transplantation protocols in hematological malignancies and rare …

S Crippa, L Santi, R Bosotti, G Porro… - Journal of Clinical …, 2019 - mdpi.com
Mesenchymal stromal cells (MSCs) are crucial elements in the bone marrow (BM) niche
where they provide physical support and secrete soluble factors to control and maintain …

[HTML][HTML] Osteoimmunology in mucopolysaccharidoses type I, II, VI and VII. Immunological regulation of the osteoarticular system in the course of metabolic …

V Opoka-Winiarska, A Jurecka, A Emeryk… - Osteoarthritis and …, 2013 - Elsevier
Summary Background Mucopolysaccharidoses (MPSs) are rare genetic diseases caused by
a deficient activity of one of the lysosomal enzymes involved in the glycosaminoglycan …

[HTML][HTML] Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells …

A Pievani, V Scagliotti, FM Russo, I Azario, B Rambaldi… - Cytotherapy, 2014 - Elsevier
Background aims Cord blood (CB) and amniotic fluid (AF) could represent new and
attractive mesenchymal stromal cell (MSC) sources, but their potential therapeutic …

Immunosuppression does not affect human bone marrow mesenchymal stromal cell efficacy after transplantation in traumatized mice brain

F Pischiutta, G D'Amico, E Dander, A Biondi, E Biagi… - …, 2014 - Elsevier
The need for immunosuppression after allo/xenogenic mesenchymal stromal cell (MSC)
transplantation is debated. This study compared the long-term effects of human (h) bone …

Extracellular matrix disruption is an early event in the pathogenesis of skeletal disease in mucopolysaccharidosis I

JM Heppner, F Zaucke, LA Clarke - Molecular genetics and metabolism, 2015 - Elsevier
Progressive skeletal and connective tissue disease represents a significant clinical burden
in all of the mucopolysaccharidoses. Despite the introduction of enzyme replacement …

[HTML][HTML] Current and Future Perspective in Hematopoietic Stem Progenitor Cell-gene Therapy for Inborn Errors of Metabolism

F Tucci, G Consiglieri, M Cossutta, ME Bernardo - HemaSphere, 2023 - journals.lww.com
Inborn errors of metabolism (IEM) are a group of rare, heterogenous diseases caused mostly
by monogenic mutations that result in disruption of metabolic pathways due to deficient …